Joe Brown
Finn Skott Andersen in Denmark

Note: In this book, 15 cancer doctors share the details of their treatment protocols and answer difficult questions about cancer. Each physician is given their own chapter in the book. The page you are viewing contains sample material; to read the rest of the book, you can place your order for the book from the publisher, Amazon, or Barnes & Noble. You can also buy the Kindle Edition.

Finn Skøtt Andersen, MD, (doctor’s website) has been the chief physician at Humlegaarden cancer clinic since 1979.  Founded in 1945, Humlegaarden is situated amidst idyllic surroundings in the small town of Humlebæk, just five miles south of Elsinore and approximately thirty miles north of Copenhagen, Denmark. Through his work with cancer patients, Dr. Andersen has become one of the most well-known and innovative cancer doctors in Scandinavia. He uses holistic methods for treating cancer, and has treated thousands of patients from all over the world during his thirty-two years at Humlegaarden. He has achieved exceptional results in his patients, especially in those with prostate cancer.

What Cancer Is and What Causes It

Describing cancer in just a few words is difficult, because cancer is actually many diseases, and several factors are implicated in their development. All human beings have small, dormant tumors in their bodies. These tumors are very little: perhaps no larger than a millimeter or two in size. Autopsies performed on the breasts of middle-aged women and the prostates of men (who died of other causes besides cancer) have revealed the presence of these dormant cancers. These little cancers are also commonly found in the thyroid gland. People can live with such small, dormant tumors for years without ever developing cancer. 
 
The small dormant tumors can, however, start to produce growth factors such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and fibroblast growth factor (FGF). These growth factors attach themselves to receptors on nearby blood vessel walls and induce biochemical processes that create new blood vessels, which then sprout out from the walls towards the dormant tumor. The sprouting vessels then grow into the tumor, thus enabling it to obtain oxygen and nutrients and grow at an accelerated rate. The production of new blood vessels from existing blood vessels is called angiogenesis.

What triggers a dormant tumor to start producing these growth factors at a certain point in time is an interesting question. Perhaps a dormant tumor may be triggered to start growing when all of the well-known cancer-promoting factors that we are exposed to in our lifetimes reach a “tipping point.” However, our experience at Humlegaarden suggests that there is usually just one primary factor which finally triggers tumor development, which is different for everyone. If patients could discover this factor, and neutralize or eliminate it, their prognoses would be majorly impacted.

Emotional trauma may be the most relevant or important factor in the development of some cancers. Pancreatic and breast cancers are psychosomatic cancers, according to our experience, especially pancreatic cancer, which often occurs after an emotional shock.  This shock can be a bankruptcy, a difficult divorce, or any traumatic event in a person’s life. Some people have an “inner balance” which allows them to cope with even the most challenging life traumas, while others can’t get them out of their systems. The energy of those traumas then accumulates in the solar plexus area of the body. Ancient Chinese doctors have said that cancers arise wherever a person has an accumulation, or overabundance, of Chi (energy) in a specific area of the body. Setting this excess energy into motion so that it leaves the body is important and necessary for treating psychosomatic cancers. Of course, environmental contamination also contributes to cancer, and there’s no doubt that it has increased the incidence of cancer in recent years.

[End Excerpt]

Order your copy of the book to finish reading this chapter. The following are additional sections contained in this chapter:

  • Cancer Treatments
  • Local Hyperthermia
  • Whole Body Hyperthermia
  • HL (High Level) Whole Body Hyperthermia
  • Low-Dose Metronomic Chemotherapy 
  • Mistletoe
  • Low-Dose Naltrexone
  • Prostate Cancer Treatment
  • The Art of Combining and Switching Cancer Therapies
  • Tumor Markers and CTCs (or Circulating Tumor Cell) Tests
  • Dietary Recommendations
  • Lifestyle Strategies for Healing
  • Exercise
  • The Importance of Treating Infections and Toxicity in the Mouth
  • Final Words

Buy the book to finish reading this chapter.


444 Pages, $39.95